Article Index

biotech stocks to buy

The Next Great Blockbuster Biotech Stock to Buy Now

biotech stock

Spending on cancer treatment has been skyrocketing globally. According to the IMS Institute of Health, spending on cancer topped $100 billion globally in 2014. That was a 10% increase from 2013.

That's why many biotech stocks tied to cancer treatments have seen triple-digit gains in the last two years.

Now, Money Morning Biotech Investing Specialist Ernie Tremblay has found a new biotech stock to buy that could be the next cancer blockbuster...

These Promising Cancer Therapies Are a Biotech "Triple Play"

biotech

On Jan. 7, 2015, CytRX Corp. announced positive results from a study of its experimental brain cancer drug, aldoxorubicin, and the company's stock immediately jumped 15.8%. Then, over the next four months, it nearly doubled.

Over the months since June 2013, when Clovis Oncology released positive trial data for both a lung cancer and a lymphoma drug, CLVS share value has soared 255%.

And just last summer, when Puma Biotechnology released positive results from a clinical trial of its breast cancer drug, neratanib, PBYI shares jumped 300% in a single session.

It's clear that investors can do very well with the right cancer drug.

But there, of course, is the rub: Finding the right cancer drug is not so easy.

I'm about to show you three companies - all sound investments - running strong in the race to fight this scourge, and the one that could very well take the prize...

The Best Biotech ETF to Buy in 2015

Biotech etf

Biotech stocks have seriously outperformed the markets in 2015, and our favorite biotech ETF has been one of the biggest winners.

In the last year, the Nasdaq Biotechnology Index has soared 48.3%. The Dow and S&P 500 are up just 7.3% and 8.6% in that time.

Here's our favorite biotech ETF to buy now...

How to Play Organovo (NYSE: ONVO) Stock After Earnings

ONVO stock

Organovo Holdings Inc. (NYSE: ONVO) stock is up 12.7% this week after the company reported quarterly and fiscal year earnings on Tuesday.

For the quarter ending March 31, ONVO reported an earnings per share (EPS) loss of $0.10. That was below the consensus estimate of a $0.09 loss.

Here's what else investors need to know about ONVO stock now...

Why Organovo Stock Is a Top Biotech Stock to Buy in 2015

Organovo stock

One of our favorite biotech stocks of 2015, Organovo stock, has climbed 41% since the end of March. And that's just the start for this revolutionary biotech investment.

You see, Organovo Holdings Inc. (NYSEMKT: ONVO) is part of one of the most exciting biotech industries on the market. It's called 3D bioprinting, and the applications are huge.

Here's a closer look at the 3D bioprinting market and why it's providing us with such a great investment opportunity.

This Top Biotech Stock Just Got a $100 Billion "Buy" Signal

Global cancer spending topped $100 billion for the first time after climbing a whopping 10% in 2014.

And that's a major "buy" signal for one of the top biotech stock picks we've been recommending at Money Morning.

According to a report from the IMS Institute of Health, rising drug prices and increased incidence of cancer led to the 10% spike in drug spending last year.

Here's what that means for our top investment...

The 3 Best Biotech Stocks to Buy at Today's Discounted Prices

Best biotech stocks

The biotech market has sold off last week, with the Nasdaq Biotechnology Index dropping 6.4% since April 23. And because of that, some of the best biotech stocks have dipped as well.

Now, investors are wondering if they should take their money to the sideline. But Money Morning's Bioscience Investing specialist Ernie Tremblay says this type of move is normal for the biotech market.

Here are three stocks we're recommending now that they're trading at discounted prices...

Why Gilead (Nasdaq: GILD) Is Still A Biotech Stock to Buy

Nasdaq: GILD

Gilead Sciences Inc. (Nasdaq: GILD) is facing criticism again this week for its highly priced Hepatitis C drug Sovaldi. The drug costs $1,000 per pill.

According to The Wall Street Journal, many states have restricted access to the drug, leaving some patients unable to afford the treatment.

But despite the criticism, Gilead (Nasdaq: GILD) stock remains one of the best biotech stocks to buy today. Here's why...

3 of the Best Biotech Stocks to Buy Today

best biotech stocks

If you're looking for the best biotech stocks on the market, you've come to the right place.

Our biotech specialists aren't considered to be among the best... they are the best.

And they picked three of the best biotech stocks to profit from today...

The Best Biotech Stocks to Buy in 2015

biotech stocks to buy in 2015

Biotech stocks to buy in 2015: Biotech was one of the most profitable sectors this year. Through Dec. 18, the S&P 500 Biotechnology Index is up 43.6% in 2014, and the Nasdaq Biotechnology Index is up 36.9%.

Those gains are three to six times as big as the broader markets'. In 2014 through Dec. 18, the Dow Jones Industrial Average is up just 6.1%, the S&P 500 10.3%, and the Nasdaq 12.8%.

With those profits in mind, we've picked the three best biotech stocks to buy in 2015, plus one bonus investment. Take a look...

These Biotech Stocks to Buy Profit from Today's "Miracle Cures"

biotech stocks to buy

When researching the best biotech stocks to buy, investors often look for companies that will cure terrible, chronic diseases.

Until recently, these biotech stocks have been elusive. But now that's changing - thanks to an industry known as personalized medicine.

In his 20 years' experience, Tremblay has covered every type of biotech stock and company on the market. And when he talks about the personalized medicine field, he describes the treatments as "miraculous." Here's why...

The Best Biotech ETF to Buy Now

biotech stocks

There are more than 1,000 biotech companies in North America alone. They cover a wide range of sectors including pharmaceuticals, biologics, generics, and medical devices.

But finding the right stocks in such a broad industry is no easy task.

That's why we've targeted the best biotech ETF to buy now. It offers investors an excellent way to play the entire industry, without having to pick a specific sector.

Here’s the pick…

Nine of the Best Stocks to Buy in October

best stocks to buy

Best stocks to buy for the week ending Sept. 26, 2014:Last week for Money Morning Members, we highlighted 9 stocks that bring readers the "best of the best" to boost their portfolios in the fall months.

Our free list includes 3 picks that protect your wealth from rising rates, three Chinese stocks poised to surge (that aren’t Alibaba), and more…

These Biotech Stocks Are Tied to the World’s Most Expensive New Drugs

biotech stocks

One of the reasons biotech stocks can be your portfolio’s biggest winners is because of the massive profits companies see after releasing a blockbuster drug – especially with the exorbitantly high prices of this year’s new treatments.

Here are a closer look at the priciest drugs – and the biotech stocks behind them…

Eight New Picks from Our "Stocks to Buy Now" List (and None Are Alibaba)

stocks to buy

Best stocks to buy for the week ending Sept. 19, 2014:Last week, U.S. market history was made when Alibaba debuted as the biggest IPO of all time. While we like BABA stock, it's not the only way to profit.

You can find all of last week's recommendations here in our newest list of the best stocks to buy now.

Including 2 top biotech picks, 2 energy stocks that take advantage of recent EPA rule changes, and more...

© 2015 Money Map Press. All Rights Reserved. Protected by copyright of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including the world wide web), of content from this webpage, in whole or in part, is strictly prohibited without the express written permission of Money Morning. 16 W. Madison St. Baltimore, MD, 21201, Email: customerservice@MoneyMorning.com